| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.13▲ | 2.13▲ | 2.14▲ | 2.14▲ | 2.20▼ |
| MA10 | 2.12▲ | 2.12▲ | 2.13▲ | 2.15▲ | 2.15▲ |
| MA20 | 2.12▲ | 2.12▲ | 2.12▲ | 2.24▼ | 2.23▼ |
| MA50 | 2.15▼ | 2.19▼ | 2.21▼ | 2.19▼ | 2.08▲ |
| MA100 | 2.23▼ | 2.29▼ | 2.27▼ | 2.29▼ | 3.69▼ |
| MA200 | 2.28▼ | 2.25▼ | 2.21▼ | 2.08▲ | 30.11▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.010▲ | 0.011▲ | -0.011▼ | 0.001▲ |
| RSI | 51.520▲ | 49.721▼ | 48.379▼ | 46.448▼ | 49.034▼ |
| STOCH | 60.417 | 60.417 | 63.750 | 35.061 | 41.133 |
| WILL %R | -37.500 | -37.500 | -33.333 | -74.359 | -68.354 |
| CCI | 62.222 | 65.497 | 65.758 | -25.814 | -30.370 |
| MA | $PHIO Price Crossed Above MA(13) | Set Alert |
|
Tuesday, September 23, 2025 05:00 AM
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary ...
|
|
Tuesday, September 23, 2025 04:56 AM
Registration Link Below for October 28, 2025 12 PM EST Presentation and Live Q&AKing of Prussia, Pennsylvania--(Newsfile Corp. - October 21, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a ...
|
|
Thursday, September 18, 2025 05:46 AM
Key updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762 Mr. Robert Bitterman, President and CEO of Phio Pharmaceuticals, will deliver an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/10/25 | 2.18 | 2.18 | 2.12 | 2.16 | 61,570 |
| 27/10/25 | 2.13 | 2.18 | 2.08 | 2.162 | 56,913 |
| 24/10/25 | 2.101 | 2.16 | 2.09 | 2.12 | 28,000 |
| 23/10/25 | 2.13 | 2.16 | 2.06 | 2.14 | 43,522 |
| 22/10/25 | 2.11 | 2.12 | 2.06 | 2.11 | 66,000 |
| 21/10/25 | 2.16 | 2.16 | 2.11 | 2.13 | 22,399 |
| 20/10/25 | 2.14 | 2.17 | 2.11 | 2.16 | 48,822 |
| 17/10/25 | 2.12 | 2.16 | 2.09 | 2.11 | 39,341 |
| 16/10/25 | 2.20 | 2.25 | 2.11 | 2.12 | 81,353 |
| 15/10/25 | 2.25 | 2.25 | 2.18 | 2.24 | 49,101 |
|
|
||||
|
|
||||
|
|